CD8A and cancer: Interestingly, although an IFN-I stimulated DC population has recently been shown to stimulate CD8+ T cells and support antitumor immunity (33, 47), other studies suggested that persistent IFN-I signaling in cancer cells contribute to resistance to antitumor immunity (48, 49).